产品名称 | NebuSelect™ Recombinant Mouse IL-18BP, hFc-tag |
---|---|
目录号 | NBL-242453 |
别名 | IL-18BP; IL-18BP; Igifbp |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q9Z0M9 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242453-100ug | 100ug | Inquire | Inquire | |
NBL-242453-1mg | 1mg | Inquire | Inquire | |
NBL-242453-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse IL-18BP, hFc-tag
Catalog#:
NBL-242453
Description:
NebuSelect™ Recombinant Mouse IL-18BP, hFc-tag(Cat#NBL-242453) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Thr29-Ala193.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 44.7 kDa. Due to glycosylation, the protein migrates to 60-75 kDa based on Bis-Tris PAGE result.
Target Name:
IL-18BP; IL-18BP; Igifbp
Target Information:
Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.